2 recruiting, 1 active not recruiting, 1 enrolling by invitation. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Active not recruiting 1, Enrolling by invitation 1 |
Follow Anastrozole Tablets: new trials by email Literature Review of Anastrozole Tablets trials Research Report on Anastrozole Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer HRS-8080 Tablets, Letrozole tablets, Tamoxifen Citrate Tablets - Breast Cancer | Phase 3 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | 5500 | 2026-03-04 | 2026-05-22 |
| A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer HRS-8080 Tablet, Fulvestrant injection, Exemestane tablets - Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 3 | Recruiting | Shandong Suncadia Medicine Co., Ltd. | 240 | 2025-07-23 | 2026-10-02 |
| Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study TOL2506, Tamoxifen, Letrozole tablets - Breast Cancer | Phase 3 | Enrolling by invitation | Tolmar Inc. | 250 | 2022-12-28 | 2026-10-23 |
| Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer TOL2506, Tamoxifen, Letrozole Tablets - Breast Cancer | Phase 3 | Active not recruiting | Tolmar Inc. | 250 | 2021-07-01 | 2026-10-23 |
Breast Neoplasms (4) · Neoplasms (2)
Shandong Suncadia Medicine Co., Ltd. (2) · Tolmar Inc. (2)
Argentina (2) · Brazil (2) · China (2) · India (2) · Mexico (2) · Puerto Rico (2) · United States (2) · Canada (1)
E P Hamilton (1)